Intas Pharmaceuticals Ltd.
Healthcare
Bottomline: ChrysCap, SWFs-backed Intas Pharma facing headwinds
Gujarat-based drugmaker Intas Pharmaceuticals Ltd has had a nearly three-decade-long tryst with private equity investors, having raised capital from ICICI ......
Healthcare
ChrysCapital-backed Intas Pharma weighs $1-bn bid for Biogen's biosimilars biz
Intas Pharmaceuticals Ltd is preparing a bid for Biogen Inc.’s biosimilar business in a transaction that could be valued at ......
Healthcare
Ascent-backed Naari to acquire drug applications portfolio to boost US biz
Ascent Capital-backed Naari Pharma Pvt. Ltd is set to acquire a portfolio of abbreviated new drug applications (ANDAs) from a ......
Finance
How PE and M&A dealmaking turned out in healthcare sector in Jan-March
India’s healthcare sector recorded fewer private equity transactions as well as mergers and acquisitions in the first quarter of 2020 ......
Healthcare
ChrysCapital set to reinvest in another pharmaceutical portfolio firm
Homegrown private equity firm ChrysCapital is in advanced talks to increase its stake in its oldest pharmaceutical portfolio company, which ......
Healthcare
Aurobindo Pharma ends big-ticket bid for Mallinckrodt's generics biz
Drugmaker Aurobindo Pharma Ltd has walked away from the race to purchase the generics business of UK-based Mallinckrodt Plc in ......
Healthcare
Temasek-backed Intas triumphs in trademark battle against rival
The Bombay High Court has dismissed a case against Intas Pharmaceuticals Ltd filed by a rival drugmaker alleging violation of ......
Healthcare
Company watch: PE-backed Intas Pharma enjoying a healthy dose of growth
It was in 1996 that Intas Pharmaceuticals Ltd first attracted a private equity investor. Twenty-one years later, PE firms’ interest ......
Healthcare
Temasek emerges as the frontrunner to buy stake in Intas Pharma from ChrysCap
Singapore’s sovereign fund Temasek Holdings has emerged as the front runner in the race to acquire a little over 10 ......
Healthcare
Intas Pharma may reconsider proposed IPO, could look at PE deal to give ChrysCap part exit
Intas Pharmaceuticals Ltd, which had filed its draft red-herring prospectus (DRHP) with SEBI for a proposed initial public offering (IPO) ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News